Langford Locks services

We’re expanding to meet demand and to offer new services

April 29th, 2017

We are moving to new facilities to meet rapidly growing demand for products and services We are pleased to announce that The Native Antigen Company is moving to new, expanded bespoke facilities with effect from April 27th. 2017 These new facilities will enable us to meet the rapidly increasing demand for our products and services […]

Antibodies from The Native Antigen Company

April 19th, 2017

Antibodies are used in a wide range of research applications and immunodiagnostic assays. The reliability, reproducibility and sensitivity of an antibody is key to the success of any antibody based application and there is an increasing demand for high quality antibodies for both research and diagnostic assay development. The Native Antigen Company already has an […]

Oropouche virus nucleoprotein

Oropouche Virus – an emerging public health challenge in tropical and subtropical areas of Central and South America

March 14th, 2017

  In 2016, the World Health Organization (WHO) reported the first outbreak of Oropouche fever in the Northern part of the Cusco region of Peru, resulting in 57 reported cases of infection due to the Oropouche virus (OROV). Oropouche virus (OROV) is an RNA virus that belongs to the family Bunyaviridae. Phylogenetic analysis of OROV […]

Spring 2017 Newsletter_Page_1

Newsletter January 2017

January 25th, 2017

Our Newsletter from January 2017 includes updates on new products and services, including those summarised below. Read the full newsletter for all the details. Recombinant Envelope Proteins for Zika and Dengue Viruses We have developed recombinant envelope proteins from Zika and Dengue viruses to complement our range of NS1 proteins. These proteins will provide researchers […]

Dengue virus NS1

Dengue virus NS1 aids transfer into host mosquitoes

July 6th, 2016

Dengue virus NS1 proteins aid viral transfer into host mosquitoes   In a publication in Nature Microbiology (June 2016) Liu et al have demonstrated that Dengue virus NS1 protein has an important role to play in infecting the mosquitoes that act as vectors for Dengue virus infection. It seems that the Dengue virus NS1 protein […]

Zika Virus NS1 antigen used to generate Zika specific binders by Avacta

June 27th, 2016

The value of the Zika Virus NS1 antigen manufactured by The Native Antigen Company for the development of diagnostic assays and reagents has been demonstrated by the announcement from Avacta Life Sciences that they have used Zika Virus NS1 antigen to prepare Zika virus specific affimers. The Native Antigen Company Zika Virus NS1 antigen was […]

Zika and Usutu Virus NS1 launched

November 27th, 2015

The Native Antigen Company (NAC) announces another world first: the launch of Zika and Usutu Virus NS1 recombinant proteins expressed in our proprietary mammalian cell expression system. Zika and Usutu Virus are emerging pathogens causing increasing concern both in Brazil where a significant Zika outbreak has been occuring since 2014 and in Europe where several […]

“NS1 should be part of dengue vaccine”

October 27th, 2015

Well done to Robert, Eva and everyone at the Harris lab for their latest paper published in Science Translational Medicine. Using Native Antigen Company DENV NS1 products they have shown that anti-NS1 antibodies can protect against the pathogenic effects of NS1, and immunisation with NS1 can protect against a lethal DENV 2 challenge. This supports […]

Dengue Virus-Like Particles launched

October 5th, 2015

The Native Antigen Company Limited (‘NAC’: Oxford, UK) announces the launch of a new range of Dengue Virus-Like Particles incorporating products for all four Dengue serotypes. Virus-Like Particles (VLPs) represent an increasingly important technology for use in vaccine development and serology. VLPs consist of protein shells comprising outer proteins specific to the virus in question. […]

New publication using NAC NS1

July 2nd, 2015

We’d like to congratulate Tesfaye and her colleagues at the CDC for an excellent paper in Journal of Virological methods, using Native Antigen Company DENV, YFV and WNV NS1 products to characterise their new monoclonals. Development and characterization of mouse monoclonal antibodies against monomeric dengue virus non-structural glycoprotein 1 (NS1). Gelanew T, Poole-Smith BK, Hunsperger […]